ARPO Insider Trading Activity and SEC Form 4 Filings
ARPO insider trading summary
No open-market insider purchases or sales of Aerpio Pharmaceuticals, Inc. (ARPO) have been reported on SEC Form 4 in the past 12 months.
Latest ARPO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 8, 2020 | OrbiMed Capital GP V LLC | 10% Owner | Sell | $42K (21,400 @ $1.96) |
| Dec 8, 2020 | Orbimed Advisors LLC | 10% Owner | Sell | $42K (21,400 @ $1.96) |
| Jul 10, 2019 | Joseph H. Gardner | President | Buy | $4K (5,000 @ $0.81) |
| Jul 3, 2019 | Joseph H. Gardner | President | Buy | $4K (5,000 @ $0.90) |
| Apr 26, 2019 | AG Novartis | 10% Owner | Sell | $143K (138,704 @ $1.03) |
| Apr 26, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | $143K (138,704 @ $1.03) |
| Apr 25, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | $580K (563,096 @ $1.03) |
| Apr 25, 2019 | AG Novartis | 10% Owner | Sell | $580K (563,096 @ $1.03) |
| Apr 24, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | $17K (16,403 @ $1.03) |
| Apr 24, 2019 | AG Novartis | 10% Owner | Sell | $17K (16,403 @ $1.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.